Skip to main content
Fig. 7 | BMC Pulmonary Medicine

Fig. 7

From: Butyrate inhibits iILC2-mediated lung inflammation via lung-gut axis in chronic obstructive pulmonary disease (COPD)

Fig. 7

Changes of iILC2 proportion in the colon and lung tissues in mice with AECOPD after butyrate treatment in vivo. (A) Study flowchart for butyrate treatment in mice. (B) Flow cytometry analysis of iILC2s (Lin−CD45+CD127+ST2−KLRG1hi) and nILC2s (Lin–CD45+CD127+ST2+KLRG1int) in the lung and colon tissues. The representative gates in each group were exhibited. (C) Percentage of nILC2s and iILC2s in lungs. (D) Percentage of nILC2s and iILC2s in colons. *P < 0.05 (n = 5)

Back to article page